Evidence for dual roles of histone H3 lysine 4 in antagonizing Polycomb group function and promoting target gene expression
Genes & Development · 2024
DOI: 10.1101/gad.352181.124 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes & Development, 2024. Verfasst von Cyril S Anyetei-Anum und 10 weiteren Autor:innen. Beteiligte Einrichtung: Curriculum in Genetics and Molecular Biology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA. Hauptthemen laut MEDLINE: Histones, Drosophila Proteins, Polycomb-Group Proteins, Lysine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NCI NIH HHS, NIH HHS.
Abstract (Originalsprache)
Tight control over cell identity gene expression is necessary for proper adult form and function. The opposing activities of Polycomb and trithorax complexes determine the on/off state of cell identity genes such as the Hox factors. Polycomb group complexes repress target genes, whereas trithorax group complexes are required for their expression. Although trithorax and its orthologs function as methyltransferases specific to histone H3 lysine 4 (H3K4), there is no direct evidence that H3K4 regulates Polycomb group target genes in vivo. Using histone gene replacement in Drosophila , we provide evidence of two key roles for replication-dependent histone H3.2K4 in Polycomb target gene control. First, we found that H3.2K4 mutants mimic H3.2K4me3 in antagonizing methyltransferase activity of the PRC2 Polycomb group complex. Second, we found that H3.2K4 is also required for proper activation of Polycomb targets. We conclude that H3.2K4 directly regulates Polycomb target gene expression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Curriculum in Genetics and Molecular Biology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA.
- Integrative Program for Biological and Genome Sciences, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA.
- Department of Biology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA.
- Department of Biochemistry and Biophysics, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA.
- Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA.
- Department of Genetics, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA.
ORCID-Profile: Cyril S Anyetei-Anum, Mary P Leatham-Jensen, Geoffrey C Fox, Krzysztof Krajewski, Brian D Strahl, Jill M Dowen, A Gregory Matera, Robert J Duronio, Daniel J McKay
Förderung
- NIGMS NIH HHS
- NCI NIH HHS
- NIH HHS
- National Institute of General Medical Sciences
Zitieren
APA
Anyetei-Anum, C. S., Leatham-Jensen, M. P., Fox, G. C., Smith, B. R., Chirasani, V. R., Krajewski, K., Strahl, B. D., Dowen, J. M., Matera, A. G., Duronio, R. J., & McKay, D. J. (2024). Evidence for dual roles of histone H3 lysine 4 in antagonizing Polycomb group function and promoting target gene expression. Genes & Development. https://doi.org/10.1101/gad.352181.124
Vancouver
Anyetei-Anum CS, Leatham-Jensen MP, Fox GC, Smith BR, Chirasani VR, Krajewski K, et al. Evidence for dual roles of histone H3 lysine 4 in antagonizing Polycomb group function and promoting target gene expression. Genes & Development. 2024. doi:10.1101/gad.352181.124
BibTeX
@article{AnyeteiAnum2024,
author = {Anyetei-Anum, Cyril S and Leatham-Jensen, Mary P and Fox, Geoffrey C and Smith, B Rutledge and Chirasani, Venkat R and Krajewski, Krzysztof and Strahl, Brian D and Dowen, Jill M and Matera, A Gregory and Duronio, Robert J and McKay, Daniel J},
title = {Evidence for dual roles of histone H3 lysine 4 in antagonizing Polycomb group function and promoting target gene expression},
journal = {Genes & Development},
year = {2024},
doi = {10.1101/gad.352181.124}
}
EUVIMED